Company name: CANNAMORE
Description: Provider of a pre-clinical and clinical-stage research platform created to develop novel and improved cannabis-based treatment options.
Industry: Healthcare | Group: | Code:
Region: Middle East
Start up capital raised (USD Million):
Business status: Startup
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company graduated from BioSeedXL on March 28, 2019.
Number of active investors:
Profile last updated: 28-Oct-2019
Last known valuation:
Last known valuation date: